The UCLA SPORE in Prostate Cancer would like to congratulate the 2015-2016 Developmental Research Program awardees. This year’s projects come from various departments across campus and Cedars Sinai Medical Center, and exemplify translational research.
Dolores Di Vizio, MD, PhD
Surgery, Pathology and Laboratory Medicine and Biomedical Sciences, Cedars Sinai Medical Center
Project Title: Large Oncosomes: A Novel Approach to Liquid Biopsy in Patients with Prostate Cancer
Guoping Fan, PhD
Human Genetics, UCLA
Project Title: Genomic analysis of tumor circulating cell-free DNAs from CRPC patients in clinical trial with MEK 1/2 inhibitor Trametinib
Andrew S. Goldstein, PhD
Molecular & Medical Pharmacology, Urology, UCLA
Project Title: Role of metastasis-associated microRNAs in prostate cancer
Beatrice Knudsen, MD, PhD
Translational Pathology, Cedars Sinai Medical Center
Project Title: Deep proteomics of the DNA damage response checkpoint for drug development against lethal prostate cancer
Yi Xing, PhD
Microbiology, Immunology and Molecular Genetics, UCLA
Project Title: Transcriptomic and functional impact of the neuronal splicing factor NOVA1 in prostate cancer
David Eisenberg, PhD
Chemistry, Biochemistry and Biological Chemistry, UCLA; UCLA-DOE Institute for Genomics and Proteomics; HHMI Investigator
Project Title: P53 aggregation inhibitor as a new therapeutic approach for advanced prostate cancer
